SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-17-351459
Filing Date
2017-11-24
Accepted
2017-11-24 17:17:34
Documents
19

Document Format Files

Seq Description Document Type Size
1 F-1/A d464165df1a.htm F-1/A 2386782
2 EX-1.1 d464165dex11.htm EX-1.1 251030
3 EX-23.1 d464165dex231.htm EX-23.1 4956
4 GRAPHIC g464165g12x96.jpg GRAPHIC 132180
5 GRAPHIC g464165g14n99.jpg GRAPHIC 72303
6 GRAPHIC g464165g19r51.jpg GRAPHIC 84089
7 GRAPHIC g464165g22x82.jpg GRAPHIC 165585
8 GRAPHIC g464165g23c58.jpg GRAPHIC 9146
9 GRAPHIC g464165g23x69.jpg GRAPHIC 151747
10 GRAPHIC g464165g34c85.jpg GRAPHIC 116566
11 GRAPHIC g464165g34h71.jpg GRAPHIC 145296
12 GRAPHIC g464165g39c97.jpg GRAPHIC 88148
13 GRAPHIC g464165g44j28.jpg GRAPHIC 53550
14 GRAPHIC g464165g48d66.jpg GRAPHIC 65282
15 GRAPHIC g464165g49z57.jpg GRAPHIC 69196
16 GRAPHIC g464165g55b95.jpg GRAPHIC 2396
17 GRAPHIC g464165g56p16.jpg GRAPHIC 52080
18 GRAPHIC g464165g62c49.jpg GRAPHIC 84088
19 GRAPHIC g464165g95q26.jpg GRAPHIC 67567
  Complete submission text file 0001193125-17-351459.txt   4518029
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: F-1/A | Act: 33 | File No.: 333-220755 | Film No.: 171221706
SIC: 2834 Pharmaceutical Preparations